Prelude Therapeutics (PRLD) Cash & Equivalents (2019 - 2026)
Prelude Therapeutics' Cash & Equivalents came in at $155.2 million for Q2 2026, up 420.9% from $29.8 million a year earlier and up 83.0% from the prior quarter.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Prelude Therapeutics' Cash & Equivalents was $38.49 million, up 133.0% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -29.3% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $16.52 million in FY2024 (-43.7%), $29.34 million in FY2023 (-15.3%), $34.65 million in FY2022 (-3.4%) and $35.87 million in FY2021 (-83.6%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q2 2021.
- Year-over-year, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 113.6% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2026 (growth of 420.9%), and the weakest in Q1 2022 (a decline of 84.7%).
- Business Quant data shows PRLD's Cash & Equivalents at $84.8 million (Q1 2026), $38.49 million (Q4 2025) and $58.2 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Prelude Therapeutics | 292.88 Mn | -304.42 Mn | - | 155.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 155.20 Mn |
| Mar 31, 2026 | 84.80 Mn |
| Dec 31, 2025 | 38.49 Mn |
| Sep 30, 2025 | 58.20 Mn |
| Jun 30, 2025 | 29.80 Mn |
| Mar 31, 2025 | 44.31 Mn |
| Dec 31, 2024 | 16.52 Mn |
| Sep 30, 2024 | 15.18 Mn |
| Jun 30, 2024 | 31.87 Mn |
| Mar 31, 2024 | 28.75 Mn |
| Dec 31, 2023 | 29.34 Mn |
| Sep 30, 2023 | 19.94 Mn |
| Jun 30, 2023 | 30.49 Mn |
| Mar 31, 2023 | 22.25 Mn |
| Dec 31, 2022 | 34.65 Mn |
| Sep 30, 2022 | 56.07 Mn |
| Jun 30, 2022 | 54.75 Mn |
| Mar 31, 2022 | 55.68 Mn |
| Dec 31, 2021 | 35.87 Mn |
| Sep 30, 2021 | 61.42 Mn |
API Access
Prelude Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();